echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Sildenafil Citrate Orally Disintegrating Tablets of 3 Billion Large Varieties of New Dosage Form Kelun Pharmaceuticals Approved

    Sildenafil Citrate Orally Disintegrating Tablets of 3 Billion Large Varieties of New Dosage Form Kelun Pharmaceuticals Approved

    • Last Update: 2022-05-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
      On April 29, the official website of the State Food and Drug Administration showed that Sichuan Kelun Pharmaceutical Co.
    , Ltd.
    was approved for the production of Sildenafil Citrate Orally Disintegrating Tablets, which were reported as imitation of Category 4.

    .
    According to the latest data from Minet.
    com, in 2021, the sales of sildenafil in China's urban physical pharmacy terminals will reach a new high, breaking the 3 billion yuan mark

    .
     
     
     April 29, 2022 Information release of drug approval certificate pending collection
     
      According to the data, Sildenafil, developed by Pfizer, is the world's first phosphodiesterase type 5 selective inhibitor approved for the treatment of erectile dysfunction.
    The most widely used first-line drug in clinical practice

    .
    Orally disintegrating tablets can disintegrate without drinking water and can be placed in the mouth for a few seconds, and take effect in as fast as 12 minutes, which can meet the needs of patients for oral drugs such as convenient taking and fast onset of action

    .
     
      Sales of sildenafil in physical pharmacies in Chinese cities in recent years (unit: 100 million yuan)
      Source: Competitive landscape of physical pharmacy terminals in Chinese cities
     
      According to data from Minet.
    com, the terminal sales of sildenafil in physical pharmacies in Chinese cities have risen steadily in recent years, exceeding 2.
    5 billion yuan in 2020, and reaching a new high in 2021, breaking the 3 billion yuan mark

    .
    It is worth mentioning that sildenafil ranks first in the generic name of urinary system drugs, with a year-on-year increase of nearly 20% in 2021

    .
     
      The approved products of Sildenafil are Sildenafil Citrate Tablets and Sildenafil Citrate Orally Disintegrating Tablets.
    Among them, Sildenafil Citrate Tablets have 15
    companies with production approval, Baiyunshan 10 companies including General Pharmaceutical Factory, Qilu Pharmaceutical, Nanjing Hailing Pharmaceutical of Yangzijiang Pharmaceutical Group, and China Resources Secco Pharmaceutical have already reviewed; prior to this, only Pfizer has an import production approval for sildenafil citrate orally disintegrating tablets
    .
     
      Kelun Pharmaceuticals stated that Sildenafil Citrate Orally Disintegrating Tablets is the company's third approved andrology treatment drug after Dapoxetine Tablets and Vardenafil Hydrochloride Tablets
    .
     
      Note: The original text has been deleted
     
      Source: State Food and Drug Administration official website, company announcements, Minet database
     
      Note: Minet.
    com China's urban physical
    pharmacy terminal competition pattern database is an enlarged version of the urban physical pharmacy database that covers 297 cities and above cities nationwide (excluding county and rural physical pharmacies) and continuously monitors all categories
    .
    The above sales are calculated based on the average retail price of the product in the terminal

    .
      On April 29, the official website of the State Food and Drug Administration showed that Sichuan Kelun Pharmaceutical Co.
    , Ltd.
    was approved for the production of Sildenafil Citrate Orally Disintegrating Tablets, which were reported as imitation of Category 4.

    .
    According to the latest data from Minet.
    com, in 2021, the sales of sildenafil in China's urban physical pharmacy terminals will reach a new high, breaking the 3 billion yuan mark

    .
     
     
     April 29, 2022 Information release of drug approval certificate pending collection
     
      According to the data, Sildenafil, developed by Pfizer, is the world's first phosphodiesterase type 5 selective inhibitor approved for the treatment of erectile dysfunction.
    The most widely used first-line drug in clinical practice

    .
    Orally disintegrating tablets can disintegrate without drinking water and can be placed in the mouth for a few seconds, and take effect in as fast as 12 minutes, which can meet the needs of patients for oral drugs such as convenient taking and fast onset of action

    .
     
      Sales of sildenafil in physical pharmacies in Chinese cities in recent years (unit: 100 million yuan)
      Source: Competitive landscape of physical pharmacy terminals in Chinese cities
     
      According to data from Minet.
    com, the terminal sales of sildenafil in physical pharmacies in Chinese cities have risen steadily in recent years, exceeding 2.
    5 billion yuan in 2020, and reaching a new high in 2021, breaking the 3 billion yuan mark

    .
    It is worth mentioning that sildenafil ranks first in the generic name of urinary system drugs, with a year-on-year increase of nearly 20% in 2021

    .
     
      The approved products of Sildenafil are Sildenafil Citrate Tablets and Sildenafil Citrate Orally Disintegrating Tablets.
    Among them, Sildenafil Citrate Tablets have 15
    companies with production approval, Baiyunshan 10 companies including General Pharmaceutical Factory, Qilu Pharmaceutical, Nanjing Hailing Pharmaceutical of Yangzijiang Pharmaceutical Group, and China Resources Secco Pharmaceutical have already reviewed; prior to this, only Pfizer has an import production approval for sildenafil citrate orally disintegrating tablets
    .
     
      Kelun Pharmaceuticals stated that Sildenafil Citrate Orally Disintegrating Tablets is the company's third approved andrology treatment drug after Dapoxetine Tablets and Vardenafil Hydrochloride Tablets
    .
     
      Note: The original text has been deleted
     
      Source: State Food and Drug Administration official website, company announcements, Minet database
     
      Note: Minet.
    com China's urban physical
    pharmacy terminal competition pattern database is an enlarged version of the urban physical pharmacy database that covers 297 cities and above cities nationwide (excluding county and rural physical pharmacies) and continuously monitors all categories
    .
    The above sales are calculated based on the average retail price of the product in the terminal

    .
      On April 29, the official website of the State Food and Drug Administration showed that Sichuan Kelun Pharmaceutical Co.
    , Ltd.
    was approved for the production of Sildenafil Citrate Orally Disintegrating Tablets, which were reported as imitation of Category 4.

    .
    According to the latest data from Minet.
    com, in 2021, the sales of sildenafil in China's urban physical pharmacy terminals will reach a new high, breaking the 3 billion yuan mark

    .
     
     
     
     April 29, 2022 Information release of drug approval certificate pending collection
     
      According to the data, Sildenafil, developed by Pfizer, is the world's first phosphodiesterase type 5 selective inhibitor approved for the treatment of erectile dysfunction.
    The most widely used first-line drug in clinical practice

    .
    Orally disintegrating tablets can disintegrate without drinking water and can be placed in the mouth for a few seconds, and take effect in as fast as 12 minutes, which can meet the needs of patients for oral drugs such as convenient taking and fast onset of action

    .
     
      Sales of sildenafil in physical pharmacies in Chinese cities in recent years (unit: 100 million yuan)
      Source: Competitive landscape of physical pharmacy terminals in Chinese cities
     
      According to data from Minet.
    com, the terminal sales of sildenafil in physical pharmacies in Chinese cities have risen steadily in recent years, exceeding 2.
    5 billion yuan in 2020, and reaching a new high in 2021, breaking the 3 billion yuan mark

    .
    It is worth mentioning that sildenafil ranks first in the generic name of urinary system drugs, with a year-on-year increase of nearly 20% in 2021

    .
     
      The approved products of Sildenafil are Sildenafil Citrate Tablets and Sildenafil Citrate Orally Disintegrating Tablets.
    Among them, Sildenafil Citrate Tablets have 15
    companies with production approval, Baiyunshan 10 companies including General Pharmaceutical Factory, Qilu Pharmaceutical, Nanjing Hailing Pharmaceutical of Yangzijiang Pharmaceutical Group, and China Resources Secco Pharmaceutical have already reviewed; prior to this, only Pfizer has an import production approval for sildenafil citrate orally disintegrating tablets
    .
    enterprise enterprise enterprise
     
      Kelun Pharmaceuticals stated that Sildenafil Citrate Orally Disintegrating Tablets is the company's third approved andrology treatment drug after Dapoxetine Tablets and Vardenafil Hydrochloride Tablets
    .
     
      Note: The original text has been deleted
      
     
      Source: State Food and Drug Administration official website, company announcements, Minet database
     
      Note: Minet.
    com China's urban physical
    pharmacy terminal competition pattern database is an enlarged version of the urban physical pharmacy database that covers 297 cities and above cities nationwide (excluding county and rural physical pharmacies) and continuously monitors all categories
    .
    The above sales are calculated based on the average retail price of the product in the terminal

    .
    pharmacy pharmacy pharmacy
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.